Evidence map›Paper›PMID 39877563›Full record

ArticleBJUI compass2025

Safety and feasibility of En-bloc holmium laser enucleation for very large prostates (> 200 cc) with trainee involvement.

Feres C Maluf, Ansh Bhatia, Archan Khandekar, Diana M Lopategui, Joao G Porto, Ryan R Chen, Jean C Daher, Mohamadhusni Zarli, Robert Marcovich, Hemendra N Shah

Abstract read
In one paragraph

Article in BJUI compass, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Feres C MalufUniversity of California San Francisco San Francisco CA USA.ORCID https://orcid.org/0000-0002-3756-1624
Ansh BhatiaMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.ORCID https://orcid.org/0000-0001-6131-4837
Archan KhandekarMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Diana M LopateguiMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Joao G PortoMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.ORCID https://orcid.org/0000-0002-6495-1054
Ryan R ChenMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Jean C DaherMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Mohamadhusni ZarliDr. Kiran C. Patel College of Osteopathic Medicine Nova Southeastern University Fort Lauderdale FL USA.
Robert MarcovichMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Hemendra N ShahMiller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.ORCID https://orcid.org/0000-0002-4273-5502

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate the safety and feasibility of "en-bloc" Holmium Laser Enucleation of the Prostate (HoLEP) with trainee involvement in patients with prostates larger than 200 cc. Patients and Methods: A retrospective analysis was conducted on patients undergoing HoLEP using the "en-bloc" technique for prostate sizes > 200 cc between July-2017 and December-2023 at an academic teaching hospital. Perioperative data was collected, including patient demographics, clinical parameters, operative details and functional outcomes. Patients who continued to experience incontinence at 1 year were further followed up at 2 years to update their continence status. Sub-group analysis was performed to compare outcomes between patients with preoperative prostate size of 200-300 cc and > 300 cc. Results: The analysis included 89 patients with a mean age of 73.12 ± 8.10 years. Preoperative prostate weight ranged from 200 to 401 cc with a median of 245 cc, and median PSA was 7.71 ng/ml. Median operative time was 218.5 minutes, and median enucleated prostate volume was 164.2 cc. Median postoperative PSA was 0.4 [0.21-0.78] ng/ml. At 1-year follow-up, mean IPSS was 1 ± 2.4, Qmax was 27.03 ± 11.57 ml/s and PVR was 21.6 ± 28.6 ml. Postoperative complications included blood transfusion (5.6%), acute renal injury (4.5%), urinary tract infection (2.2%), postoperative urinary retention (2.2%) and urethral stricture (5%). Although transient urinary incontinence was noted in 41.6% at 1-3-months, complete continence was achieved in 83.3% and 96.3% at 1 and 2 years postoperatively, respectively. Subgroup analysis showed significant differences in operative time and enucleated weight between prostates 200-300 cc and > 300 cc, but no significant differences in postoperative IPSS, PVR or Qmax at 3-months. Conclusion: "En-bloc" HoLEP is a feasible and safe procedure for prostates larger than 200 cc, demonstrating favourable perioperative and functional outcomes despite the extended operative times and involvement of trainees.

Indexed as

benign prostatic hyperplasia (BPH)En‐blocholmium laser enucleation

Identifiers

PMID39877563
PMCPMC11771494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.